S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Buy THIS stock before Taiwan is attacked (Ad)
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
Buy THIS stock before Taiwan is attacked (Ad)
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
This Tech Stock Could be the Next Amazon (Ad)pixel
UN food chief: Billions needed to avert unrest, starvation
'War of the states': EV, chip makers lavished with subsidies
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Buy THIS stock before Taiwan is attacked (Ad)
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
Buy THIS stock before Taiwan is attacked (Ad)
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
This Tech Stock Could be the Next Amazon (Ad)pixel
UN food chief: Billions needed to avert unrest, starvation
'War of the states': EV, chip makers lavished with subsidies
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Buy THIS stock before Taiwan is attacked (Ad)
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
Buy THIS stock before Taiwan is attacked (Ad)
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
This Tech Stock Could be the Next Amazon (Ad)pixel
UN food chief: Billions needed to avert unrest, starvation
'War of the states': EV, chip makers lavished with subsidies
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Buy THIS stock before Taiwan is attacked (Ad)
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
Buy THIS stock before Taiwan is attacked (Ad)
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
This Tech Stock Could be the Next Amazon (Ad)pixel
UN food chief: Billions needed to avert unrest, starvation
'War of the states': EV, chip makers lavished with subsidies
NASDAQ:SILK

Silk Road Medical - SILK Stock Forecast, Price & News

$39.13
+0.20 (+0.51%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$39.07
$40.64
50-Day Range
$38.09
$55.57
52-Week Range
$27.30
$58.04
Volume
735,001 shs
Average Volume
701,160 shs
Market Capitalization
$1.50 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$52.83

Silk Road Medical MarketRank™ Forecast

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
36.9% Upside
$53.57 Price Target
Short Interest
Bearish
6.06% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.74
Upright™ Environmental Score
News Sentiment
0.52mentions of Silk Road Medical in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$12.46 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.51) to ($1.32) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.06 out of 5 stars

Medical Sector

560th out of 1,004 stocks

Surgical & Medical Instruments Industry

59th out of 104 stocks


SILK stock logo

About Silk Road Medical (NASDAQ:SILK) Stock

Silk Road Medical, Inc. engages in the development and manufacturing of medical devices to treat neurovascular diseases. Its products include ENROUTE transcarotid neuroprotection system, ENROUTE transcarotid stent system, and ENROUTE transcarotid peripheral access kit. The company was founded by Tony M. Chou and Michi Garrison on March 21, 2007 and is headquartered in Sunnyvale, CA.

Receive SILK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.

SILK Stock News Headlines

5 Stocks to Buy Immediately
America’s #1 stock picker issues 5 buy alerts – one of which is positioned to be the next Tesla. Just click to claim your copy. pixel
Silk Road Medical Gets a Fundamental Supporter
Does Silk Road Medical Have a Smooth Path Forward?
5 Stocks to Buy Immediately
America’s #1 stock picker issues 5 buy alerts – one of which is positioned to be the next Tesla. Just click to claim your copy. pixel
Citigroup upgrades Silk Road Medical (SILK) to a Hold
Q4 2022 Silk Road Medical Inc Earnings Call
SILK Silk Road Medical, Inc
Is Silk Road Medical (SILK) a Great Stock to Invest in?
See More Headlines
Receive SILK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.

SILK Company Calendar

Last Earnings
2/28/2023
Today
4/01/2023
Next Earnings (Estimated)
5/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SILK
Employees
352
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$53.57
High Stock Price Forecast
$70.00
Low Stock Price Forecast
$43.00
Forecasted Upside/Downside
+35.0%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
5 Analysts

Profitability

Net Income
$-55,010,000.00
Pretax Margin
-39.68%

Debt

Sales & Book Value

Annual Sales
$138.64 million
Book Value
$4.30 per share

Miscellaneous

Free Float
35,516,000
Market Cap
$1.50 billion
Optionable
Not Optionable
Beta
1.22

Key Executives

  • Erica J. RogersErica J. Rogers
    President, Chief Executive Officer & Director
  • Lucas W. BuchananLucas W. Buchanan
    Chief Financial & Operating Officer
  • Sumaira Macdonald
    Executive Director-Medical
  • Tammy Leitsinger
    VP-Professional Education & Medical Affairs
  • Robert A. Nicholas
    Vice President-Operations & Engineering













SILK Stock - Frequently Asked Questions

Should I buy or sell Silk Road Medical stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SILK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SILK, but not buy additional shares or sell existing shares.
View SILK analyst ratings
or view top-rated stocks.

What is Silk Road Medical's stock price forecast for 2023?

5 brokers have issued 12-month price targets for Silk Road Medical's stock. Their SILK share price forecasts range from $43.00 to $70.00. On average, they expect the company's share price to reach $53.57 in the next year. This suggests a possible upside of 36.9% from the stock's current price.
View analysts price targets for SILK
or view top-rated stocks among Wall Street analysts.

How have SILK shares performed in 2023?

Silk Road Medical's stock was trading at $52.85 at the beginning of 2023. Since then, SILK stock has decreased by 26.0% and is now trading at $39.13.
View the best growth stocks for 2023 here
.

When is Silk Road Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our SILK earnings forecast
.

How were Silk Road Medical's earnings last quarter?

Silk Road Medical, Inc (NASDAQ:SILK) issued its earnings results on Tuesday, February, 28th. The company reported ($0.34) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.37) by $0.03. The business earned $40.07 million during the quarter, compared to the consensus estimate of $37.35 million. Silk Road Medical had a negative trailing twelve-month return on equity of 63.30% and a negative net margin of 39.81%. Silk Road Medical's revenue was up 41.8% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.42) EPS.

What guidance has Silk Road Medical issued on next quarter's earnings?

Silk Road Medical updated its FY 2023 earnings guidance on Tuesday, February, 28th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $176.00 million-$184.00 million, compared to the consensus revenue estimate of $172.70 million.

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Raytheon Technologies (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), Honeywell International (HON), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA).

When did Silk Road Medical IPO?

(SILK) raised $75 million in an initial public offering on Thursday, April 4th 2019. The company issued 4,700,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

What is Silk Road Medical's stock symbol?

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

How do I buy shares of Silk Road Medical?

Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Silk Road Medical's stock price today?

One share of SILK stock can currently be purchased for approximately $39.13.

How much money does Silk Road Medical make?

Silk Road Medical (NASDAQ:SILK) has a market capitalization of $1.50 billion and generates $138.64 million in revenue each year. The company earns $-55,010,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis.

How many employees does Silk Road Medical have?

The company employs 352 workers across the globe.

How can I contact Silk Road Medical?

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The official website for the company is www.silkroadmed.com. The company can be reached via phone at (408) 720-9002, via email at investors@silkroadmed.com, or via fax at 408-720-9013.

This page (NASDAQ:SILK) was last updated on 4/1/2023 by MarketBeat.com Staff